University Medical Center of the Johannes Gutenberg University Mainz

healthcare DE

6

Publications

22,903

Citations

0

Researchers

Publications

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann , Stijn E. Verleden , Mark Kuehnel +11 more

In our small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection. The universality and clini...

2020 New England Journal of Medicine 5667 citations

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Mohammed Eslam , Philip N. Newsome , Shiv Kumar Sarin +29 more

2020 Journal of Hepatology 3964 citations

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

María Reig , Alejandro Forner , Jordi Rimola +13 more

2021 Journal of Hepatology 3634 citations

Large-scale association analysis identifies new risk loci for coronary artery disease

Panos Deloukas , Stavroula Kanoni , Christina Willenborg +97 more

2012 Nature Genetics 1646 citations

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas , Igor Puzanov , Reinhard Dummer +33 more

2015 The Lancet Oncology 1528 citations

Institution Info

Type: healthcare
Country: DE
Publications: 6
Citations: 22,903

External Links

Identifiers

ROR: https://ror.org/00q1fsf04